Lipum, HiloProbe, SDB Biotech where the finalists when Connect’s pitch price was announced at Biotech Umeå Investment Day.
Drugs against chronic inflammatory diseases, diagnosis of colorectal cancer and a biochip for diagnostics with smart phones, are the solutions that were awarded when Connect’s pitch price was announced at Biotech Umeå Investment Day in Stockholm. The finalists, Lipum, HiloProbe, SDB Biotech, and the other companies participating in the event were here to meet investors and to add to their networks – an important aspect in building viable businesses.
All companies at Biotech Umeå Investment Day have solutions that can make us healthier in one way or another. Among the nine life science companies aspiring for Connects pitch prize, the jury chose the winner based on four criteria; the idea, the entrepreneur, the growth potential and credibility. Winning gives Lipum a chance to meet more investors, the prize is a fee participation at Connect 2 Capital 2019.
The three finalists
- Winner Lipum develops unique drugs for patients suffering from chronic inflammatory diseases. They have a world-class drug candidate.
- First runner-up, HiloProbe has developed a tool that helps identify the right treatment method for patients with colorectal cancer.
- Second runner-up, SDB Biotech combines the advantages of microfluids, nanotechnology and mobile internet, to make healthcare and livestock diagnostics instantly available with a smartphone diagnostics biochip system.
See winning company Lipum
Einar Pontén, CEO Lipum, presents the winning company Lipum.